NASDAQ:NERV Minerva Neurosciences (NERV) Insider Trading & Ownership $7.30 -0.04 (-0.54%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$7.15▼$7.3650-Day Range$7.30▼$10.5252-Week Range$1.26▼$14.70Volume8,677 shsAverage Volume19,891 shsMarket Capitalization$51.03 millionP/E RatioN/ADividend YieldN/APrice Target$11.00 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Minerva Neurosciences (NASDAQ:NERV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$192,503.15 Get NERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Minerva Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NERV Insider Buying and Selling by Quarter Minerva Neurosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/1/2023Frederick W AhlholmCFOSell3,580$4.48$16,038.40 5/1/2023Geoff RacePresidentSell22,082$3.85$85,015.70 5/1/2023Remy LuthringerCEOSell23,753$3.85$91,449.05 (Data available from 1/1/2013 forward) NERV Insider Trading Activity - Frequently Asked Questions Who is on Minerva Neurosciences's Insider Roster? The list of insiders at Minerva Neurosciences includes David Kupfer, Frederick W Ahlholm, Geoff Race, Joseph H Reilly, and Remy Luthringer. Learn more on insiders at NERV. What percentage of Minerva Neurosciences stock is owned by insiders? 6.40% of Minerva Neurosciences stock is owned by insiders. Learn more on NERV's insider holdings. Which Minerva Neurosciences insiders have been selling company stock? The following insiders have sold NERV shares in the last 24 months: David Kupfer ($48,958.80), Frederick W Ahlholm ($16,038.40), Geoff Race ($85,015.70), and Remy Luthringer ($91,449.05). How much insider selling is happening at Minerva Neurosciences? Insiders have sold a total of 105,050 Minerva Neurosciences shares in the last 24 months for a total of $241,461.95 sold. More Insider Trading Tools from MarketBeat Related Companies: AEON Biopharma Insider Selling Rezolute Insider Selling Hookipa Pharma Insider Selling Immix Biopharma Insider Selling Clearside Biomedical Insider Selling Vistagen Therapeutics Insider Selling Immunic Insider Selling Eyenovia Insider Selling Clene Insider Selling Dianthus Therapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:NERV) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.